ISTH0036

DB18606InvestigationalGene Therapies

ISTH0036 is a synthetic 14-mer phosphorothioate antisense oligonucleotide directed against TGF-beta2 mRNA.

Mechanism: Pharmacologically active on Transforming growth factor beta-2 proprotein
Curator reviewed
Code names: ISTH0036

Resolves to

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with ISTH0036, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.